$ 150

$ 250

A one-time payment to Resdevco by Wize Israel in an amount of $650 shall be due no later than the second anniversary of the receipt of Food and Drug Administration (“FDA”) approval (the “Deferred Amount”); however, following FDA approval, if annual royalties due to Resdevco by Wize Israel exceed the Minimum Royalties (as defined in the License Agreement), an amount equal to 50% of such excess shall be added towards settlement of the Deferred Amount. As to royalty payments, Resdevco shall be entitled to the greater of $0.60 per unit sold, or a percentage of revenues, not to exceed 10%, from sales made in the United States and other countries, excluding Israel, China and Ukraine, but not less than the Minimum Royalties.

Percentage of contingent obligation

37.00%

License agreement, description

Representing the minimum commitment to pay royalties based on the upcoming January 2021 payment in an amount of $150 and an amount of $100 which represents a termination fee payable to Resdevco if the Company exercises its right to terminate the License Agreement.

License Agreement (Details) - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
License Agreement (Details) - USD ($) $ in Thousands	Jan. 31, 2021	Jan. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
License Agreement (Textual)
Percentage of discount rate			10.00%
Payments for future royalties amounts	$ 150	$ 150	$ 250	$ 250
Deferred Costs			$ 650
License agreement, description			A one-time payment to Resdevco by Wize Israel in an amount of $650 shall be due no later than the second anniversary of the receipt of Food and Drug Administration (“FDA”) approval (the “Deferred Amount”); however, following FDA approval, if annual royalties due to Resdevco by Wize Israel exceed the Minimum Royalties (as defined in the License Agreement), an amount equal to 50% of such excess shall be added towards settlement of the Deferred Amount. As to royalty payments, Resdevco shall be entitled to the greater of $0.60 per unit sold, or a percentage of revenues, not to exceed 10%, from sales made in the United States and other countries, excluding Israel, China and Ukraine, but not less than the Minimum Royalties.
Recognized liability			$ 250
Percentage of contingent obligation			37.00%
Penalty payment			$ 100,000
Subsequent Event [Member]
License Agreement (Textual)
License agreement, description	Representing the minimum commitment to pay royalties based on the upcoming January 2021 payment in an amount of $150 and an amount of $100 which represents a termination fee payable to Resdevco if the Company exercises its right to terminate the License Agreement.